Details of the Drug Reposition

General Information of This Drug (ID: DMGZQEF)

Drug Name
Mifepristone   DMGZQEF
Synonyms
Mifedren; HRA-052015; Mifepristone (Cushing's disease); ACTH modulator (Cushing's disease), HRA; Adrenocorticotropic hormone modulator (Cushing's disease), HRA Pharma; Mifepristone (Cushing's disease), HRA pharma
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pregnancy disorder with abortive outcome DISRPLP6 N.A. Discontinued in Phase 2 [1]
Cushing disease DISOG6P2 5A70 Discontinued in Phase 2 [2]
------------------------------------------------------------------------------------

References

1 A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
2 A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica